Tandem Diabetes Stock Forward View - Simple Moving Average
| TNDM Stock | USD 18.47 0.44 2.44% |
Tandem Diabetes Care's Simple Moving Average forecast is generated from the selected price series and evaluated against observed values. Forecast accuracy depends on how stable the recent price trend has been — trending markets suit some models better than others. The forecast is recalculated with each session so it does not rely on stale inputs. A small Bias confirms the model is not systematically over- or under-predicting. The Simple Moving Average model projects Tandem Diabetes at 18.25 for the next trading day, below the most recent closing price. All values shown are model-generated projections and should be evaluated alongside other analytical inputs.
Simple Moving Average Price Forecast For the 8th of May
Over a 90-day horizon, the Simple Moving Average model forecasts Tandem Diabetes at 18.25 for the next trading day, with a mean absolute deviation of 0.99 , mean absolute percentage error of 0.04 , and sum of absolute errors of 58.13 .This represents a tight forecast with good short-term tracking of Tandem Diabetes' price movement. This output is intended for short-term analytical reference.
Stock Forecast Pattern
| Backtest Tandem Diabetes | Tandem Diabetes Price Prediction | Research Analysis |
Forecasted Value
The projected range for Tandem Diabetes reflects the model's ability to define credible downside and upside scenarios for the next trading day. The projected band runs from roughly 12.31 on the downside to about 24.19 on the upside. The wide range indicates elevated uncertainty in short-term projections.
Model Predictive Factors
The table below summarizes the Simple Moving Average model's error metrics for Tandem Diabetes stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.| AIC | Akaike Information Criteria | 115.2654 |
| Bias | Arithmetic mean of the errors | 0.033 |
| MAD | Mean absolute deviation | 0.9852 |
| MAPE | Mean absolute percentage error | 0.0447 |
| SAE | Sum of the absolute errors | 58.125 |
Other Forecasting Options for Tandem Diabetes
Bollinger Bands applied to Tandem Diabetes Stock price data measure how far Tandem Diabetes has deviated from its recent average relative to its own volatility. This distinction drives the choice of forecasting model applied to Tandem Diabetes' price data. On-balance volume for Tandem Diabetes Stock creates a running indicator of buying versus selling pressure in Tandem Diabetes. Price departures from the channel boundary often mean-revert, offering tactical signals for Tandem Diabetes'.Tandem Diabetes Related Equities
These stocks are related to Tandem Diabetes within the Health Care space and can be used for peer review, pricing, or spreading risk. Revenue and margin checks across this group help investors set expectations for Tandem Diabetes' results. A stock that beats its peers on many metrics often deserves a closer look from value-focused investors. Combining quantitative ratios with qualitative context such as management quality and market position sharpens peer comparisons.
| Risk & Return | Correlation |
Tandem Diabetes Market Strength Events
Market strength indicators for Tandem Diabetes quantify how the stock responds to shifts in volume and sentiment. These indicators capture shifts in momentum that may precede significant price moves in Tandem Diabetes. The Market Facilitation Index measures how efficiently price moves relative to volume — rising MFI with rising volume signals strong trend participation. Monitoring these indicators for Tandem Diabetes through complete market cycles reveals recurring patterns.
Tandem Diabetes Risk Indicators
Analyzing Tandem Diabetes' risk indicators separates symmetric price swings from asymmetric downside exposure. Understanding and quantifying the risks present in Tandem Diabetes helps place recent price behavior in context. These metrics are most informative when compared against similar equities with comparable growth profiles and market capitalization. When semi-deviation is high relative to standard deviation, Tandem Diabetes' losses have been disproportionately large compared to gains.
| Mean Deviation | 3.74 | |||
| Semi Deviation | 3.85 | |||
| Standard Deviation | 5.93 | |||
| Variance | 35.17 | |||
| Downside Variance | 15.35 | |||
| Semi Variance | 14.85 | |||
| Expected Short fall | -4.79 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Tandem Diabetes Short Properties
Short-interest data for Tandem Diabetes reveals whether bearish conviction in the market is gaining traction. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 67.28 million | |
| Cash And Short Term Investments | 292.67 million |